Either through genetic mutational study on FFAR2/3 or their interactive action with targeted agonists and antagonists would help in exploring the exact mechanism of action of FFAR2/3 against various gut hormonal comorbidities such as obesity and T2D. Here, FFAR2 is linked to type 2 diabetes mellitus.